Identification of Amino Acid Residues Essential for von Willebrand Factor Binding to Platelet Glycoprotein Ib. CHARGED-TO-ALANINE SCANNING MUTAGENESIS OF THE A1 DOMAIN OF HUMAN VON WILLEBRAND FACTOR

作者: Tadashi Matsushita , J. Evan Sadler

DOI: 10.1074/JBC.270.22.13406

关键词:

摘要: At sites of vascular injury, von Willebrand factor (VWF) mediates platelet adhesion through binding to glycoprotein Ib (GPIb). The VWF-GPIb interaction was investigated by clustered charged-to-alanine scanning mutagenesis VWF domain A1 between His-473 and Gly-716. Recombinant variants were assayed for conformation-dependent monoclonal antibody NMC-4, ristocetin-induced botrocetin-induced platelets, direct botrocetin. Substitutions at 32 amino acids had no effect on function. epitope NMC-4 depended charged residues Asp-514 Arg-632 not segments previously implicated peptide inhibition studies, Cys-474-Pro-488 Leu-694-Pro-708. Glu-626 in the segment Asp-520-Lys-534 abolished GPIb but did affect binding, suggesting that these regions are required modulation ristocetin GPIb. Mutations Glu-596 Lys-599 decreased without affecting its botrocetin, this interacts directly with Alanine substitutions Arg-545 Glu-497-Arg-511 Arg-687-Glu-689 caused increased These results, locations disease type 2B mutations, suggest two acidic containing Cys-509-Cys-695 disulfide (Glu-497-Arg-511, Arg-687-Val-698) one predominantly basic region (Met-540-Arg-578) cooperate inhibit a distinct site domain. This is relieved specific modulators or subendothelial connective tissue.

参考文章(41)
J P Girma, Y Takahashi, A Yoshioka, J Diaz, D Meyer, Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thrombosis and Haemostasis. ,vol. 64, pp. 326- 332 ,(1990) , 10.1055/S-0038-1647310
R L Burke, C Pachl, M Quiroga, S Rosenberg, N Haigwood, O Nordfang, M Ezban, The functional domains of coagulation factor VIII:C. Journal of Biological Chemistry. ,vol. 261, pp. 12574- 12578 ,(1986) , 10.1016/S0021-9258(18)67127-3
Z. Dong, R.S. Thoma, D.L. Crimmins, D.W. McCourt, E.A. Tuley, J.E. Sadler, Disulfide bonds required to assemble functional von Willebrand factor multimers. Journal of Biological Chemistry. ,vol. 269, pp. 6753- 6758 ,(1994) , 10.1016/S0021-9258(17)37439-2
M. Sugimoto, J. Dent, R. McClintock, J. Ware, Z.M. Ruggeri, Analysis of structure-function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand's factor by expression of deletion mutants. Journal of Biological Chemistry. ,vol. 268, pp. 12185- 12192 ,(1993) , 10.1016/S0021-9258(19)50324-6
A.M. Randi, S Jorieux, E.A. Tuley, C Mazurier, J.E. Sadler, Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin. Journal of Biological Chemistry. ,vol. 267, pp. 21187- 21192 ,(1992) , 10.1016/S0021-9258(19)36815-2
AS Ribba, O Christophe, A Derlon, G Cherel, V Siguret, JM Lavergne, JP Girma, D Meyer, G Pietu, Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease. Blood. ,vol. 83, pp. 833- 841 ,(1994) , 10.1182/BLOOD.V83.3.833.BLOODJOURNAL833833
V Vicente, R A Houghten, Z M Ruggeri, Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. Journal of Biological Chemistry. ,vol. 265, pp. 274- 280 ,(1990) , 10.1016/S0021-9258(19)40226-3